Toxic hepatitis due to enalapril in childhood

Pediatrics International

Volumn 45, Issue 6, 2003, Pages 755-757

  Baş, Vedat ^a   Erkan, Tülay ^a,b   Çalişkan, Salim ^a   Sever, Lale ^a   Kasapçopur, Özgür ^a   Özbay, Gülsen ^a   Arisoy, Nil ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Türker Apt No:9/4 ^*  (Turkey)

Author keywords

Abnormal hepatic function; Angio converting enzyme inhibitor; Antihypertensive treatment; Enalapril; Hepatotoxicity; Hypertension; Nephrotic syndrome; Toxic hepatitis

Indexed keywords

ENALAPRIL; PREDNISOLONE;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; LABORATORY TEST; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; TOXIC HEPATITIS; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CHILD; ENALAPRIL; FEMALE; HEPATITIS, TOXIC; HUMANS; LIVER; NEPHROTIC SYNDROME;

EID: 1642562672     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2003.01817.x     Document Type: Article

References (9)

1. Roy CC, Silverman A, Alagille D. Liver disorders associated with drugs, parenteral nutrition, and various systemic diseases. In: Roy CC, Silverman A, Alagille D (eds). Pediatric Clinical Gastroenterology, 4th edn. Mosby-Year Book, St Louis, 1995; 891-903.
2. Jeserich M, Ihling C, Allgaier HP, Berg PA, Heilmann C. Acute liver failure due to enalapril. Herz 2000; 25: 689-93.
3. Quilez C, Palazon JM, Chulia T, Cordoba YC. Hepatotoxicity by enalapril. Gastroenterol. Hepatol. 1999; 22: 113-14.
4. Hartleb M, Biernat U, Kochel A. Drug-induced liver damage: A three-year study of patients from one gastroenterological department. Med. Sci. Monit. 2002; 8: 292-6.
5. Gonzalez de la Puenta MA, Calderon E, Espinosa R, Rincon M, Varela JM. Fatal hepatotoxicity associated with enalapril. Ann. Pharmacother. 2001; 35: 1492.
6. Larrey D, Babany G, Bernuau J et al. Fulminant hepatitis after lisinopril administration. Gastroenterology 1990; 99: 1832-3.
7. Hagley MT, Benak RL, Hulisz DT. Suspected cross-reactivity of enalapril-and captopril-induced hepatotoxicity. Ann. Pharmacother. 1992; 26: 780-81.
8. Hagley MT, Hulisz DT, Burns CM. Hepatotoxicity associated with angiotensin-converting enzyme inhibitors. Ann. Pharmacother. 1993; 27: 228-31.
9. Jurima-Romet M, Huang HS. Enalapril hepatotoxicity in the rat. Effects of modulators of cytochrome P450 and glutathione. Biochem. Pharmacol. 1992; 44: 1803-10.